SCHEMBL31729241

SCHEMBL31729241

Cc1c(Cl)cccc1-c1c(O)cnc2c(N)ncnc12

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ CNR2 P34972 1/20 0.34
▸ HAVCR2 Q8TDQ0 1/20 0.34
▸ USP7 Q93009 2/20 0.34
▸ PIK3CD O00329 2/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ ADK P55263 1/20 0.33
▸ PIK3CG P48736 3/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ CLK1 P49759 2/20 0.32
▸ LIMK1 P53667 1/20 0.32
▸ PIK3CA P42336 1/20 0.32
▸ PIK3CB P42338 1/20 0.32
▸ PRKDC P78527 1/20 0.32
▸ MAP4K4 O95819 1/20 0.32
▸ BCL2 P10415 2/20 0.31
▸ MCL1 Q07820 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31728528 0.85 IDO1 (0.36) IDO1ALDH1A1CNR2HAVCR2PIK3CD
SCHEMBL31727897 0.82 LIMK1 (0.36) IDO1ALDH1A1CNR2USP7PIK3CD
SCHEMBL31727894 0.79 PIK3CD (0.37) IDO1ALDH1A1CNR2PIK3CDPIK3CG
SCHEMBL31728390 0.77 MAPT (0.40) PIK3CDPIK3CGPIK3CAPIK3CBPRKDC
SCHEMBL31729134 0.76 GSK3B (0.41) ALDH1A1PIK3CDHSP90AA1PIK3CGKDM4E
SCHEMBL31729240 0.75 PIK3CD (0.37) IDO1ALDH1A1CNR2PIK3CDPIK3CG
SCHEMBL31727816 0.74 IDO1 (0.33) IDO1PIK3CDMAP4K4
SCHEMBL31728730 0.72 PDE5A (0.36) IDO1ALDH1A1PIK3CDADKLIMK1
SCHEMBL31728766 0.71 PIK3CD (0.38) IDO1ALDH1A1CNR2PIK3CDPIK3CG
SCHEMBL10835918 0.69 IDO1 (0.43) IDO1ALDH1A1CNR2HAVCR2USP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
Send feedback